181 related articles for article (PubMed ID: 25071346)
41. Dietary fenugreek and onion attenuate cholesterol gallstone formation in lithogenic diet-fed mice.
Reddy RR; Srinivasan K
Int J Exp Pathol; 2011 Oct; 92(5):308-19. PubMed ID: 21756271
[TBL] [Abstract][Full Text] [Related]
42. Augmented cholesterol absorption and sarcolemmal sterol enrichment slow small intestinal transit in mice, contributing to cholesterol cholelithogenesis.
Xie M; Kotecha VR; Andrade JD; Fox JG; Carey MC
J Physiol; 2012 Apr; 590(8):1811-24. PubMed ID: 22331417
[TBL] [Abstract][Full Text] [Related]
43. Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice.
Xie Y; Newberry EP; Kennedy SM; Luo J; Davidson NO
J Lipid Res; 2009 May; 50(5):977-87. PubMed ID: 19136665
[TBL] [Abstract][Full Text] [Related]
44. Activation of Estrogen Receptor G Protein-Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice.
Wang HH; de Bari O; Arnatt CK; Liu M; Portincasa P; Wang DQ
Hepatology; 2020 Dec; 72(6):2077-2089. PubMed ID: 32112420
[TBL] [Abstract][Full Text] [Related]
45. miRNA-223 Suppresses Mouse Gallstone Formation by Targeting Key Transporters in Hepatobiliary Cholesterol Secretion Pathway.
Zhao F; Ma S; Zhou Y; Wei B; Hao Z; Cui X; Xing L; Liu G; Jin L; Ma T; Shi L
Int J Biol Sci; 2021; 17(15):4459-4473. PubMed ID: 34803510
[TBL] [Abstract][Full Text] [Related]
46. Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function.
van Erpecum KJ; Wang DQ; Moschetta A; Ferri D; Svelto M; Portincasa P; Hendrickx JJ; Schipper M; Calamita G
J Lipid Res; 2006 Jan; 47(1):32-41. PubMed ID: 16224116
[TBL] [Abstract][Full Text] [Related]
47. The effect of Tauroursodeoxycholic acid (TUDCA) and gut microbiota on murine gallbladder stone formation.
Lu Q; Jiang Z; Wang Q; Hu H; Zhao G
Ann Hepatol; 2021; 23():100289. PubMed ID: 33217585
[TBL] [Abstract][Full Text] [Related]
48. Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis.
Freudenberg F; Leonard MR; Liu SA; Glickman JN; Carey MC
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G205-14. PubMed ID: 20430874
[TBL] [Abstract][Full Text] [Related]
49. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine.
Wang HH; Wang DQ
Hepatology; 2005 Oct; 42(4):894-904. PubMed ID: 16175613
[TBL] [Abstract][Full Text] [Related]
50. Lack of adiponectin promotes formation of cholesterol gallstones in mice.
Ogiyama H; Kamada Y; Kiso S; Araki H; Yamada T; Nishihara T; Watabe K; Tochino Y; Kihara S; Funahashi T; Kanno K; Shimomura I; Tsutsui S; Tazuma S; Hayashi N
Biochem Biophys Res Commun; 2010 Aug; 399(3):352-8. PubMed ID: 20659429
[TBL] [Abstract][Full Text] [Related]
51. Effects of tegaserod on bile composition and hepatic secretion in Richardson ground squirrels on an enriched cholesterol diet.
Mathison R; Shaffer E; Pfannkuche HJ; Earnest D
Lipids Health Dis; 2006 Jun; 5():15. PubMed ID: 16792807
[TBL] [Abstract][Full Text] [Related]
52. Gallbladder motor function, plasma cholecystokinin and cholecystokinin receptor of gallbladder in cholesterol stone patients.
Zhu J; Han TQ; Chen S; Jiang Y; Zhang SD
World J Gastroenterol; 2005 Mar; 11(11):1685-9. PubMed ID: 15786550
[TBL] [Abstract][Full Text] [Related]
53. Piperine prevents cholesterol gallstones formation in mice.
Song XY; Xu S; Hu JF; Tang J; Chu SF; Liu H; Han N; Li JW; Zhang DM; Li YT; Chen NH
Eur J Pharmacol; 2015 Mar; 751():112-7. PubMed ID: 25645812
[TBL] [Abstract][Full Text] [Related]
54. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice.
Wang HH; Afdhal NH; Gendler SJ; Wang DQ
Gastroenterology; 2006 Jul; 131(1):210-22. PubMed ID: 16831603
[TBL] [Abstract][Full Text] [Related]
55. [Oil of Piper longum unsaponifiable matter prevents cholesterol gallstone formation].
Xu S; Hu JF; Chu SF; Han N; Li JW; Li YT; Chen NH
Yao Xue Xue Bao; 2013 Jul; 48(7):1178-82. PubMed ID: 24133988
[TBL] [Abstract][Full Text] [Related]
56. Role of Baicalin and Liver X Receptor Alpha in the Formation of Cholesterol Gallstones in Mice.
Chen G; Wu S
Gastroenterol Res Pract; 2020; 2020():1343969. PubMed ID: 32382260
[TBL] [Abstract][Full Text] [Related]
57. Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity.
Zhang Z; Du Z; Liu Q; Wu T; Tang Q; Zhang J; Huang C; Huang Y; Li R; Li Y; Zhao Y; Zhang G; Zhou J; Huang H; Fang Z; He J
Metabolism; 2021 May; 118():154728. PubMed ID: 33581130
[TBL] [Abstract][Full Text] [Related]
58. Hepatic cholesterol transport from plasma into bile: implications for gallstone disease.
Zanlungo S; Rigotti A; Nervi F
Curr Opin Lipidol; 2004 Jun; 15(3):279-86. PubMed ID: 15166783
[TBL] [Abstract][Full Text] [Related]
59. Gallstone formation and gallbladder mucosal changes in mice fed a lithogenic diet.
Chang HJ; Suh JI; Kwon SY
J Korean Med Sci; 1999 Jun; 14(3):286-92. PubMed ID: 10402171
[TBL] [Abstract][Full Text] [Related]
60. Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis.
Wang DQ; Lammert F; Cohen DE; Paigen B; Carey MC
Am J Physiol; 1999 Mar; 276(3):G751-60. PubMed ID: 10070053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
